The Entire Alzheimer’s Care Pathway as Addressed by the ACCESS-AD Project & Siemens Healthineers
Based on the provided text, here’s a breakdown of the entire Alzheimer’s care pathway, and how the ACCESS-AD project (with Siemens Healthineers as a key partner) aims to improve it:
1. early detection & Risk Assessment:
* Current Challenge: Diagnostic shortages, long waiting times for testing.
* ACCESS-AD Solution:
* Blood Tests: Development and validation of blood tests for early detection of Alzheimer’s biomarkers. Future goal of at-home blood sample collection for increased accessibility and frequency of testing. Analysis will be performed on Siemens Healthineers’ laboratory platforms.
* data Analysis: Utilizing AI to analyze blood tests, image data, and digital health data to predict treatment response and identify patients at increased risk of complications.
2. Diagnosis:
* Current Challenge: Limited capacity in specialized centers, long waiting times for imaging.
* ACCESS-AD Solution:
* MRI (Magnetic Resonance Imaging): Development and clinical introduction of advanced MRI solutions beyond specialized centers. This includes:
* Compact, helium-free DryCool magnet technologies: Reducing infrastructure requirements and costs.
* AI-supported workflows & image reconstruction: Improving efficiency and image quality.
* Accelerated skull protocols: Significantly shortening examination times.
* PET (Positron Emission Tomography): Development and clinical introduction of advanced PET/CT solutions beyond specialized centers.
* Standardized Processes: Implementing standardized processes for diagnosis across Europe.
3. Therapy Decision & treatment:
* Current Challenge: new disease-modifying therapies are available, but access is limited by diagnostic bottlenecks.
* ACCESS-AD Solution:
* facilitating Access: Making advanced diagnostics and therapies accessible to more patients.
* Pilot Study: Conducting a pilot study examining combinations of drug therapies and lifestyle changes to optimize treatment plans.
4. Monitoring of Therapy Progress:
* Current Challenge: need for ongoing monitoring to assess treatment effectiveness.
* ACCESS-AD Solution:
* MRI & PET Imaging: Utilizing MRI and PET imaging to monitor therapy progress.
* Data Analysis: Continued analysis of image data, blood tests, and digital health data to track treatment response.
5.Ongoing Care & Management:
* Current Challenge: Fragmented and delayed processes in Alzheimer’s care.
* ACCESS-AD Solution:
* Real-World Evidence Collection: Collecting real-world evidence from over 500 patients in Europe.
* Integrated Ecosystem: Creating an Alzheimer’s ecosystem that accompanies patients throughout their journey, from diagnosis to ongoing monitoring.
* AI & Digital Tools: Leveraging AI and digital tools to improve care coordination and patient management.
Overall Goals of ACCESS-AD (and Siemens Healthineers’ role):
* Improve Care: Through standardized processes and state-of-the-art solutions.
* Increase Accessibility: making advanced diagnostics and therapies available to everyone in Europe.
* Scalability & Fairness: Making precise diagnostics scalable and fair across Europe.
* Reduce burden on Healthcare Systems: By reducing bottlenecks and enabling earlier intervention.
* Focus on Disease Management: Shifting from solely symptom management to proactive disease management.
Key takeaway: The project aims to create a comprehensive, patient-centered, and technologically advanced Alzheimer’s care pathway that addresses current limitations and improves outcomes for patients across Europe.